Market Analysis — MEADOWVIEW PSYCHIATRIC HOSPITAL
NJ market | 4 hospitals | HHI: 3,922 (Concentrated)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
4
Hospitals in Market
661
Total Beds
$0.8B
Market Revenue
Concentrated
HHI: 3,922
None
Moat Rating (0/10)
#4
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantageweak
Switching Costslow
Market Share3.4%
Top 3 Concentration96.6%
Network Density0.61
Margin vs Market-8.3%
Bed Util vs Market+28.0%
What This Means
This hospital has a none moat — no moat — commoditized market position, pricing power limited. The NJ market is highly concentrated — few dominant players, potential antitrust concerns (HHI: 3,922).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full NJ market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| JERSEY CITY MEDICAL CENTER | 289 | $457M | 55.1% | 43.7% |
| PALISADES MEDICAL CENTER | 186 | $191M | 23.0% | 28.1% |
| HUDSON REGIONAL HOSPITAL | 102 | $153M | 18.4% | 15.4% |
Regional Payer Mix
■ Medicare 17%■ Medicaid 4%■ Commercial 79%